Clorox (NYSE:CLX) was downgraded by JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a note issued to investors on Monday, Marketbeat Ratings reports. They presently have a $139.00 target price on the stock, down from their prior target price of $159.00. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of 9.11% from the stock’s previous close.

A number of other research analysts have also recently commented on CLX. Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a research report on Monday, December 31st. BMO Capital Markets set a $175.00 price objective on Clorox and gave the stock a “buy” rating in a report on Tuesday, February 5th. Wells Fargo & Co restated a “hold” rating and issued a $157.00 price objective on shares of Clorox in a research note on Thursday, February 21st. Credit Suisse Group began coverage on Clorox in a research note on Wednesday, March 6th. They issued an “outperform” rating and a $172.00 price objective on the stock. Finally, Barclays reaffirmed a “hold” rating and set a $142.00 price objective on shares of Clorox in a report on Wednesday, February 6th. Six investment analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $151.21.

NYSE:CLX opened at $152.94 on Monday. The company has a current ratio of 1.15, a quick ratio of 0.66 and a debt-to-equity ratio of 3.08. The company has a market capitalization of $19.94 billion, a P/E ratio of 24.43, a P/E/G ratio of 3.86 and a beta of 0.32. Clorox has a 12 month low of $113.57 and a 12 month high of $167.70.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.32 by $0.08. Clorox had a return on equity of 105.97% and a net margin of 12.65%. The business had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the prior year, the business earned $1.77 earnings per share. Clorox’s revenue for the quarter was up 4.0% on a year-over-year basis. As a group, sell-side analysts expect that Clorox will post 6.33 EPS for the current year.

In related news, SVP Andrew J. Mowery sold 5,340 shares of the business’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $156.44, for a total transaction of $835,389.60. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Matthew T. Laszlo sold 10,585 shares of the stock in a transaction dated Wednesday, February 6th. The stock was sold at an average price of $153.89, for a total value of $1,628,925.65. Following the sale, the senior vice president now directly owns 17,994 shares in the company, valued at approximately $2,769,096.66. The disclosure for this sale can be found here. 1.40% of the stock is owned by company insiders.

Hedge funds have recently bought and sold shares of the business. Athena Capital Advisors LLC purchased a new stake in Clorox in the 4th quarter worth approximately $25,000. Meeder Asset Management Inc. bought a new position in shares of Clorox in the fourth quarter worth $26,000. Capital Financial Planning LLC bought a new position in shares of Clorox in the fourth quarter worth $32,000. City Holding Co. raised its position in shares of Clorox by 150.0% in the fourth quarter. City Holding Co. now owns 250 shares of the company’s stock worth $39,000 after buying an additional 150 shares in the last quarter. Finally, G&S Capital LLC raised its position in shares of Clorox by 46.4% in the fourth quarter. G&S Capital LLC now owns 262 shares of the company’s stock worth $40,000 after buying an additional 83 shares in the last quarter. 76.89% of the stock is owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: Net Asset Value

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.